Vaxcyte Inc (PCVX)
88.54
+0.15
(+0.17%)
USD |
NASDAQ |
Nov 22, 16:00
89.00
+0.46
(+0.52%)
After-Hours: 20:00
Vaxcyte Total Liabilities (Quarterly): 142.11M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 142.11M |
| June 30, 2024 | 101.14M |
| March 31, 2024 | 107.32M |
| December 31, 2023 | 167.45M |
| September 30, 2023 | 93.34M |
| June 30, 2023 | 69.44M |
| March 31, 2023 | 63.39M |
| December 31, 2022 | 52.56M |
| September 30, 2022 | 52.75M |
| June 30, 2022 | 45.12M |
| Date | Value |
|---|---|
| March 31, 2022 | 43.17M |
| December 31, 2021 | 40.32M |
| September 30, 2021 | 48.11M |
| June 30, 2021 | 41.03M |
| March 31, 2021 | 55.41M |
| December 31, 2020 | 46.98M |
| September 30, 2020 | 39.74M |
| June 30, 2020 | 33.04M |
| March 31, 2020 | 24.68M |
| December 31, 2019 | 172.07M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
24.68M
Minimum
Mar 2020
172.07M
Maximum
Dec 2019
71.96M
Average
52.66M
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc | 126.92B |
| Merck & Co Inc | 72.97B |
| Embecta Corp | 2.031B |
| Arrowhead Pharmaceuticals Inc | 544.78M |
| Dyne Therapeutics Inc | 63.30M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.560B |
| Shareholders Equity (Quarterly) | 3.418B |